09:29 AM EDT, 10/21/2024 (MT Newswires) -- Matthew K Fust, Director, around October 17, 2024, sold 21,788 shares in Neumora Therapeutics ( NMRA ) for $370,962. Following the Form 4 filing with the SEC, Fust has control over a total of 20,100 shares of the company, with 20,100 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1885522/000161071724000511/xslF345X05/form4.xml

Price: 16.01, Change: -0.48, Percent Change: -2.91